Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.

Plasma and urinary oestrogens were measured in nine breast cancer patients (eight postmenopausal women and one man) before and during treatment with the aromatase inhibitor 4-hydroxyandrostenedione. Urinary oestrogens were measured by using a highly specific GC-MS method. Plasma levels of oestrone,...

Descripción completa

Detalles Bibliográficos
Autores principales: Johannessen, D. C., Adlercreutz, H., Fotsis, T., Lønning, P. E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968556/
https://www.ncbi.nlm.nih.gov/pubmed/8135918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968556/
https://www.ncbi.nlm.nih.gov/pubmed/8135918

Ejemplares similares